In a context marked by the rapid emergence of Novel Psychoactive Substances (NPS), forensic and toxicology laboratories must continuously adapt their analytical scope. The quarterly recommendations published by the Center for Forensic Science Research & Education (CFSRE) have become a key reference for monitoring these developments and adjusting forensic screening strategies accordingly.

The Q1 2026 update, developed in collaboration with the NPS Committee of the Society of Forensic Toxicologists (SOFT), highlights newly emerging substances of interest, revises the analytical priority of several compounds, and continues—since late 2024—to include target metabolites in order to strengthen the relevance of routine LC‑MS/MS and HRMS methods.

As a distributor, Bertin Bioreagent supports laboratories in implementing these recommendations by offering Cayman reference standards covering the recommended NPS scope, including parent compounds, metabolites, and isotopically labeled standards. This approach is essential to secure analytical methods, improve the identification of emerging substances, and remain aligned with current forensic requirements.